Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study

Pathology Research and Practice

Volumn 206, Issue 11, 2010, Pages 735-739

  Xie, Fang ^a,b   Wang, Qin ^b   Chen, Yongjing ^b   Gu, Yongping ^a   Mao, Hui ^b   Zeng, Wang ^c   Zhang, Xueguang ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Breast; Ductal carcinoma in situ; Invasive ductal carcinoma; OX40; OX40L

Indexed keywords

CD134 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; OX40 LIGAND; PROGESTERONE RECEPTOR;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BREAST BIOPSY; BREAST CARCINOGENESIS; BREAST FIBROADENOMA; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MALIGNANT TRANSFORMATION; PILOT STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE SPECIFICITY; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FIBROADENOMA; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; OX40 LIGAND; RECEPTORS, OX40; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77958451808     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.05.016     Document Type: Article

References (30)

1. Gravestein L.A., Borst J. Tumor necrosis factor receptor family members in the immune system. Semin. Immunol. 1998, 10:423-434.
2. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?. Nat. Rev. Immunol. 2003, 3:609-620. (Review).
3. De Smedt T., Smith J., Baum P., Fanslow W., Butz E., Maliszewski C. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo. J. Immunol. 2002, 168:661-670.
4. Baum P.R., Gayle R.B., Ramsdell F., Srinivasan S., Sorensen R.A., Watson M.L., et al. Molecular characterization of murine and human OX-40/OX-40 ligand systems: indetification of a human OX-40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 1994, 13:3992-4001.
5. + T cells with homology to tumor necrosis factor. J. Exp. Med. 1994, 180:757-762.
6. Mendel I., Shevach E.M. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function. Immunology 2006, 117:196-204.
7. Kim M.Y., Bekiaris V., McConnell F.M., Gaspal F.M., Raykundalia C., Lane P.J. OX40 signals during priming on dendritic cells inhibit CD4 T cell proliferation: IL-4 switches off OX40 signals enabling rapid proliferation of Th2 effectors. J. Immunol. 2005, 174:1433-1437.
8. Vu M.D., Clarkson M.R., Yagita H., Turka L.A., Sayegh M.H., Li X.C. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J. Immunol. 2006, 176:1394-1401.
9. Lavelle E.C., McNeela E., Armstrong M.E., Leavy O., Higgins S.C., Mills K.H. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J. Immunol. 2003, 171:2384-2392.
10. Williams C.A., Murray S.E., Weinberg A.D., Parker D.C. OX40-mediated differentiation to effector function requires IL-2 receptor signaling but not CD28, CD40, IL-12Rbeta2, or T-bet. J. Immunol. 2007, 178:7694-7702.
11. Ruby C.E., Redmond W.L., Haley D., Weinberg A.D. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses. Eur. J. Immunol. 2007, 37:157-166.
12. Nohara C., Akiba H., Nakajima A., Inoue A., Koh C.S., Ohshima H., et al. Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells. J. Immunol. 2001, 166:2108-2115.
13. Lane P. Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J. Exp. Med. 2000, 191:201-206. (Review).
14. Imura A., Hori T., Imada K., Ishikawa T., Tanaka Y., Maeda M., et al. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J. Exp. Med. 1996, 183:2185-2195.
15. Imura A., Hori T., Imada K., et al. OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implication for the possible involvement of OX40 in leukemic cell infiltration. Blood 1997, 89:2951-2958.
16. Xie F., Wang Q., Chen Y., Gu Y., Shi Q., Ge Y., et al. Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues. Tissue Antigens 2006, 67:307-317.
17. Wang Q., Chen Y., Ge Y., Sun J., Shi Q., Ju S., et al. Characterization and functional study of five novel monoclonal antibodies against human OX40L highlight reverse signalling: enhancement of IgG production of B cells and promotion of maturation of DCs. Tissue Antigens 2004, 64:566-574.
18. Chiodoni C., Iezzi M., Guiducci C., Sangaletti S., Alessandrini I., Ratti C., et al. Triggering CD40 on endothelial cells contributes to tumor growth. J. Exp. Med. 2006, 203:2409-2412.
19. Tringler B., Zhuo S., Pilkington G., Torkko K.C., Singh M., Lucia M.S., et al. B7-h4 is highly expressed in ductal and lobular breast cancer. Clin. Cancer Res. 2005, 11:1842-1848.
20. Tavassoéli F.A., Devilee P. Pathology and Genetics Tumours of the Breast and Female Genital Organs [M] 2003, IARC Press, Lyon, p. 10.
21. Jacobs T.W., Gown A.M., Yaziji H., Barnes M.J., Schnitt S.J. Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J. Clin. Oncol. 1999, 17:1983-1987.
22. Yamaguchi T., Ohshima K., Tsuchiya T., Suehuji H., Karube K., Nakayama J., et al. The comparison of expression of cutaneous lymphocyte-associated antigen (CLA), and Th1- and Th2-associated antigens in mycosis fungoides and cutaneous lesions of adult T-cell leukemia/lymphoma. Eur. J. Dermatol. 2003, 13:553-559.
23. Tsuchiya T., Ohshima K., Karube K., Yamaguchi T., Suefuji H., Hamasaki M., et al. Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. Blood 2004, 103:236-241.
24. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br. J. Haematol. 1991, 79:428-437.
25. Hara I., Yoshioka K., Hori A., Ohsawa A., Yokoo S. Adult T-cell leukemia involving the central nervous system after remission of adult respiratory distress syndrome. Chest 1993, 104:1921-1923.
26. Hashiguchi T., Tara M., Niina K., Higuchi I., Arimura K., Osame M., et al. Adult T-cell leukemia (ATL) cells which express neural cell adhesion molecule (NCAM) and infiltrate into the central nervous system. Intern. Med. 2002, 41:34-38.
27. de Parseval A., Grant C.K., Sastry K.J., Elder J.H. Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. J. Virol. 2006, 80:3088-3091.
28. Takahashi Y., Tanaka Y., Yamashita A., Koyanagi Y., Nakamura M., Yamamoto N. OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection. J. Virol. 2001, 75:6748-6757.
29. Jourdan P., Vendrell J.P., Huguet M.F., Segondy M., Bousquet J., Pène J., et al. Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells. J. Immunol. 2000, 165:716-724.
30. Gotsman I., Sharpe A.H., Lichtman A.H. T-cell costimulation and coinhibition in atherosclerosis. Circ. Res. 2008, 103:1220-1231.